Document ID: chunk:federal_register_of_legislation:F2022L01382:reg:8:p1
Version: federal_register_of_legislation:F2022L01382
Segment Type: reg
Provision Reference: reg 8 (pt 1/2)
Character Range: 3463–6469

8               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, portal vein thrombosis or death from portal vein thrombosis is connected with the circumstances of a person's relevant service:
(1)          having cirrhosis of the liver at the time of the clinical onset of portal vein thrombosis;
(2)          having a disorder that is associated with a hypercoagulable state at the time of the clinical onset of portal vein thrombosis;
Note: hypercoagulable state is defined in the Schedule 1 - Dictionary.
(3)          having an intra-abdominal malignant neoplasm or a myeloproliferative neoplasm at the time of the clinical onset of portal vein thrombosis;
Note: myeloproliferative neoplasm is defined in the Schedule 1 - Dictionary.
(4)          having abdominal surgery within the 6 months before the clinical onset of portal vein thrombosis;
Note: Examples of abdominal surgery include bariatric surgery, colorectal surgery, hepatic resection, splenectomy and endoscopic treatment of gastro-oesophageal varices.
(5)          having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of portal vein thrombosis;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(6)          taking a drug from the specified list of drugs within the 30 days before the clinical onset of portal vein thrombosis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(7)          taking didanosine for at least the 3 years before the clinical onset of portal vein thrombosis;
(8)          having compression of the portal vein at the time of the clinical onset of portal vein thrombosis;
Note: Examples of a mass or structure that can cause compression of the portal vein include an abscess or hydatid cyst in the liver, retroperitoneal haematomas and neoplasms, excluding pregnancy.
(9)          having infection or inflammation involving the portal vein or a contiguous tissue or organ at the time of the clinical onset of portal vein thrombosis;
Note: Examples of infection or inflammation involving a contiguous tissue or organ include acute and chronic pancreatitis, appendicitis, diverticulitis and liver abscess.
(10)      having active tuberculosis disease involving the abdomen at the time of the clinical onset of portal vein thrombosis;
Note: active tuberculosis disease is defined in the Schedule 1 - Dictionary.
(11)      having cytomegalovirus infection of new onset within the 30 days before the clinical onset of portal vein thrombosis;
(12)      having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the 2 months before the clinical onset of portal vein thrombosis;
Note: SARS-CoV-2 is the virus which causes coronavirus disease 2019 (COVID-19).
(13)      having foreign body penetration or occlusion of the portal vein, splenic vein or superior mesenteric vein within the 30